Intermediate for Ticagrelor. Ticagrelor(trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor. Ticagrelor is an antagonist of the P2Y12 receptor. Ticagrelor has been approved by US FDA in on July 20, 2011.
Product Name: (1R,2S)-2-(3,4-Difluorophenyl)cyclopropanaminium (2R)-hydroxy(phenyl)ethanoate
CAS Number: 376608-71-8
Molecular Weight:  321.323
Molecular Formula:  C17H17F2NO3
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.